Grifols, S.A.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About GRFS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Find out what a historical investment in Grifols, S.A. would be worth today using our GRFS stock calculator.
$7.48B
-
0.00%
880.34K
$9.06
$8.80
$8.80
$9.96
$5.79
Ready to start your investing journey with Stake?
Open an accountGRFS FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in GRFS
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GRFS
on Stake
Buy GRFS from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of GRFS from only US$10 with fractional shares
